Catheter Ablation

• 

  Subject Areas on Research

  • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). 
  • 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). 
  • 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion). 
  • 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: Executive summary. 
  • 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary. 
  • 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. 
  • 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias. 
  • A Genetic Cardiomyocyte Ablation Model for the Study of Heart Regeneration in Zebrafish. 
  • A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett's oesophagus. 
  • A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. 
  • A review on the management of epilepsy associated with hypothalamic hamartomas. 
  • A three-dimensional finite element model of radiofrequency ablation with blood flow and its experimental validation. 
  • Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities. 
  • Ablation of atrial fibrillation during coronary artery bypass grafting: Late outcomes in a Medicare population. 
  • Ablation of persistent atrial fibrillation: Challenges and solutions. 
  • Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques. 
  • Ablative Approaches for Pulmonary Metastases. 
  • Ablative therapies for Barrett's esophagus. 
  • Acoustic radiation force impulse imaging of myocardial radiofrequency ablation: initial in vivo results. 
  • Acoustic radiation force impulse imaging of thermally- and chemically-induced lesions in soft tissues: preliminary ex vivo results. 
  • Acute and long-term efficacy and safety of catheter cryoablation of the cavotricuspid isthmus for treatment of type 1 atrial flutter. 
  • Adjunct and minimally invasive techniques for the diagnosis and treatment of vertebral tumors. 
  • Alcohol ablation of the intraventricular septum in symptomatic patients with hypertrophic obstructive cardiomyopathy. 
  • Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. 
  • An in vitro assessment of acoustic radiation force impulse imaging for visualizing cardiac radiofrequency ablation lesions. 
  • Anesthesia for catheter ablation procedures. 
  • Anticoagulation after Ablation for Atrial Fibrillation. 
  • Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation. 
  • Assessment of LV Myocardial Scar Before Atrial Fibrillation Ablation. 
  • Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial. 
  • Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas. 
  • Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures. 
  • Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. 
  • Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug? 
  • Atrial fibrillation ablation in practice: assessing CABANA generalizability. 
  • Atrial fibrillation ablation using a closed irrigation radiofrequency ablation catheter. 
  • Atrial fibrillation and kidney disease: stuck outside the CABANA. 
  • Atrial fibrillation in heart failure: what should we do? 
  • Atrial fibrillation mapping strategies: The hunt is on. 
  • Atrioventricular nodal re-entrant tachycardia ablation in a centenarian. 
  • Atrioventricular nodal reentrant tachycardia in children: effect of slow pathway ablation on fast pathway function. 
  • Biatrial maze procedure versus pulmonary vein isolation for atrial fibrillation during mitral valve surgery: New analytical approaches and end points. 
  • Bleeding after antithrombotic therapy in patients with acute ischemic heart disease: is it the drugs or how we use them? 
  • Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma. 
  • Bronchial thermoplasty for severe asthma. 
  • CABANA: underpowered and with detrimental protocol changes: is 'ablation salvation'?-Reply by the authors of the CABANA trial. 
  • Can catheter ablation of atrial fibrillation reverse heart failure with preserved ejection fraction? 
  • Can we improve the identification of ventricular scar to guide substrate-based ventricular tachycardia ablation? 
  • Cardioversion and subsequent quality of life and natural history of atrial fibrillation. 
  • Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation-Reply. 
  • Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 
  • Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery. 
  • Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Catheter Ablation of Mid-Myocardial Ventricular Tachycardia by Simultaneous Unipolar Radiofrequency Ablation With Half-Normal Saline Irrigation. 
  • Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design. 
  • Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials. 
  • Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. 
  • Catheter ablation of atrial fibrillation in cardiac amyloidosis. 
  • Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction. 
  • Catheter ablation of atrial fibrillation in the elderly. 
  • Catheter ablation of atrial fibrillation in the elderly: where do we stand? 
  • Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials. 
  • Catheter ablation of para-Hisian atrial tachycardias: Is "earliest" still synonymous with "best"? 
  • Catheter ablation of rotational activity in atrial fibrillation: A barren oasis? 
  • Catheter ablation of sinoatrial node reentrant tachycardia. 
  • Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. 
  • Catheter ultrasound phased-array transducers for thermal ablation: a feasibility study. 
  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. 
  • Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study? 
  • Challenges and implementation of radiation-force imaging with an intracardiac ultrasound transducer. 
  • Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. 
  • Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation. 
  • Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. 
  • Coblation of suprastomal granulomas in tracheostomy-dependent children. 
  • Cognitive dysfunction in atrial fibrillation. 
  • Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. 
  • Combined ultrasonic thermal ablation with interleaved ARFI image monitoring using a single diagnostic curvilinear array: a feasibility study. 
  • Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation. 
  • Comparative atrioventricular node properties after radiofrequency ablation and operative therapy of atrioventricular node reentry. 
  • Comparison of Acute Histologic and Biomechanical Effects of Radiofrequency Ablation and Cryoablation on Periarticular Structures in a Swine Model. 
  • Comparison of electrophysiologic effects of propofol and isoflurane-based anesthetics in children undergoing radiofrequency catheter ablation for supraventricular tachycardia. 
  • Complications after percutaneous radiofrequency ablation of renal tumors. 
  • Conduction velocity in the tricuspid valve-inferior vena cava isthmus is slower in patients with type I atrial flutter compared to those without a history of atrial flutter. 
  • Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? 
  • Continuous anticoagulation with catheter ablation: answers and questions. 
  • Contrast in intracardiac acoustic radiation force impulse images of radiofrequency ablation lesions. 
  • Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation. 
  • Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial. 
  • Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia. 
  • Cryoablation for atrial fibrillation and antiarrhythmic drug pretreatment: a single referral center experience. 
  • Current status of minimally invasive ablative techniques in the treatment of small renal tumours. 
  • Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies. 
  • Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. 
  • Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. 
  • Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies. 
  • Direct His bundle pacing post AVN ablation. 
  • Direct Thrombin Inhibition During Left-Sided Catheter Ablation: More Than Just an Alternative? 
  • Disproportionate costs and charges for pediatric catheter ablation: supply and demand... or just supply? 
  • Do new tools help us identify substrate to target for ablation in ventricular tachycardia? 
  • Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria. 
  • Early management of atrial fibrillation to prevent cardiovascular complications. 
  • Ebstein's anomaly of the tricuspid valve: a Wolf(f) in sheep's clothing. 
  • Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction. 
  • Editorial commentary: Atrial fibrillation ablation with cryoenergy: It׳s "Cool"; it׳s "Non-inferior"; Is it better? 
  • Editorial commentary: Pulsed field catheter ablation in atrial fibrillation: The promising future of an old technology. 
  • Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. 
  • Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. 
  • Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma. 
  • Effect of skin electrode location on radiofrequency ablation lesions: an in vivo and a three-dimensional finite element study. 
  • Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial. 
  • Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials. 
  • Endoscopic approaches for early-stage esophageal cancer: current options. 
  • Endoscopic treatment modalities for gastroesophageal reflux disease. 
  • Endovascular treatment of varicose veins. 
  • Epicardial ganglionated plexus ablation: Safety considerations beyond the atria. 
  • Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa. 
  • Esophagus silhouette extraction and reconstruction from fluoroscopic views for cardiac ablation procedure guidance. 
  • Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model. 
  • Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure. 
  • Experience with more than 500 minimally invasive hepatic procedures. 
  • Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF. 
  • Feasibility of near real-time lesion assessment during radiofrequency catheter ablation in humans using acoustic radiation force impulse imaging. 
  • Feasibility study of real-time three-dimensional intracardiac echocardiography for guidance of interventional electrophysiology. 
  • Focal therapy for prostate cancer. 
  • Freedom from atrial fibrillation after catheter ablation: Survival of the fittest. 
  • Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation. 
  • Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice. 
  • Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries. 
  • Health Disparities in the Treatment of Supraventricular Tachycardia in Pediatric Patients. 
  • Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia. 
  • Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation. 
  • Heart Failure and Atrial Fibrillation, Like Fire and Fury. 
  • Hematometra after thermal balloon endometrial ablation in a patient with cervical incompetence. 
  • Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment? 
  • Highlights of Heart Rhythm 2005, the Annual Scientific Sessions of the Heart Rhythm Society, May 4-7, 2005, New Orleans, Louisiana. 
  • Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study. 
  • Iatrogenic left atrial tachycardias: where are we? 
  • Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. 
  • Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations. 
  • Imaging-guided radiofrequency ablation of cystic renal neoplasms. 
  • Impact of interruptions in radiofrequency energy delivery on lesion characteristics. 
  • Impedance Guided Radiofrequency Ablation for Atrial Fibrillation: Something Old Is New Again. 
  • Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both? 
  • In vitro monitoring of the dynamic elasticity changes during radiofrequency ablation with acoustic radiation force impulse imaging. 
  • In vitro temperature map of cardiac ablation demonstrates the effect of flow on lesion development. 
  • In vivo assessment of myocardial stiffness with acoustic radiation force impulse imaging. 
  • In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. 
  • In-hospital management of patients with atrial flutter. 
  • Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation. 
  • Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA. 
  • Initial anesthetic experience during combined epicardial-endocardial treatment of atrial fibrillation. 
  • Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. 
  • Insurance status and the treatment of myocardial infarction at academic centers. 
  • Integrated catheter for 3-D intracardiac echocardiography and ultrasound ablation. 
  • Interpreting the Results of Intention-to-Treat, Per-Protocol, and As-Treated Analyses of Clinical Trials. 
  • Interventional procedures for facial pain. 
  • Intracardiac acoustic radiation force impulse imaging: a novel imaging method for intraprocedural evaluation of radiofrequency ablation lesions. 
  • Intracardiac echocardiography and acoustic radiation force impulse imaging of a dynamic ex vivo ovine heart model. 
  • Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. 
  • Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma. 
  • Is There a Role for Combination, Single-Session Selective Transarterial Embolization and Microwave Ablation for Large Renal Masses? 
  • Is there a mortality benefit of atrial fibrillation ablation? 
  • Juxtametallic Bipolar Bone Radiofrequency Ablation: Thermal Monitoring in an Ex-Vivo Model with Specimen MRI and Histopathologic Correlation. 
  • Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. 
  • Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis. 
  • Left atrial remodeling: shape before size? 
  • Left atrial tachycardia originating from the mitral annulus-aorta junction. 
  • Liver ablation guidance with acoustic radiation force impulse imaging: challenges and opportunities. 
  • Local control without resection. 
  • Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. 
  • Long-term oral anticoagulant after catheter ablation for atrial fibrillation. 
  • Long-term outcomes following microwave ablation for liver malignancies. 
  • Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases. 
  • Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. 
  • MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations. 
  • MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial. 
  • Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. 
  • Management of advanced neuroendocrine tumors with hepatic metastasis. 
  • Management of pediatric tachyarrhythmias on mechanical support. 
  • Management of small renal tumors with radiofrequency ablation. 
  • Management of the child with Wolff-Parkinson-White syndrome and supraventricular tachycardia: model for cost effectiveness. 
  • Materials for multifunctional balloon catheters with capabilities in cardiac electrophysiological mapping and ablation therapy. 
  • Maximum voltage-guided catheter ablation of typical atrial flutter: making a good procedure even better? 
  • Measurements of the left atrium and pulmonary veins for analysis of reverse structural remodeling following cardiac ablation therapy. 
  • Mechanism and magnitude of bipolar electrogram directional sensitivity: Characterizing underlying determinants of bipolar amplitude. 
  • Mechanochemical ablation for symptomatic great saphenous vein reflux: A two-year follow-up. 
  • Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation. 
  • Methods of monitoring thermal ablation of soft tissue tumors - A comprehensive review. 
  • Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center. 
  • Microwave versus saline-linked radiofrequency (Aquamantys) assisted liver resection in a porcine liver resection model. A safety and feasibility pilot study. 
  • Minimally invasive surgery using ablative modalities for the localized renal mass. 
  • Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma. 
  • Neuromodulation therapy for atrial fibrillation. 
  • New Pacemaker Implantation After Alcohol Septal Ablation: How Sharp Is the Double-Edged Sword? 
  • New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. 
  • Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes. 
  • Obstructive sleep apnea is associated with increased rotor burden in patients undergoing focal impulse and rotor modification guided atrial fibrillation ablation. 
  • Omnipolar Versus Bipolar Electrode Mapping in Patients With Atrial Fibrillation Undergoing Catheter Ablation. 
  • Ongoing Management of Patients With Supraventricular Tachycardia. 
  • Optimizing ethyl cellulose-ethanol delivery towards enabling ablation of cervical dysplasia. 
  • Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. 
  • Osteoid osteoma and osteoblastoma. 
  • Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial. 
  • Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. 
  • Outcomes associated with ablation compared to combined ablation and transilluminated powered phlebectomy in the treatment of venous varicosities. 
  • Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. 
  • Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. 
  • Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. 
  • Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. 
  • Pace mapping the fast pathway in patients with atrioventricular nodal reentrant tachycardia: Koch's triangle or the Bermuda Triangle? 
  • Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation. 
  • Paradigm shift in the management of gastroesophageal reflux disease. 
  • Paradoxical Cerebral Air Embolism after Cardiac Ablation in Williams-Beuren Syndrome: A Clinico-Pathological Correlation. 
  • Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. 
  • Patterns of Care for Atrial Fibrillation Before, During, and at Discharge From Hospitalization: From the Get With The Guidelines-Atrial Fibrillation Registry. 
  • Patterns of recurrence after ablation of colorectal cancer liver metastases. 
  • Pediatric electrophysiology. 
  • Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. 
  • Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. 
  • Performance of a new cardiac cryoablation system in the treatment of cavotricuspid valve isthmus-dependent atrial flutter. 
  • Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation. 
  • Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions. 
  • Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. 
  • Postoperative nausea and vomiting in children and adolescents undergoing radiofrequency catheter ablation: a randomized comparison of propofol- and isoflurane-based anesthetics. 
  • Predicting AF recurrence after catheter ablation: Is it time to use the force? 
  • Predicting atrial fibrillation recurrence after ablation in patients with heart failure: Validity of the APPLE and CAAP-AF risk scoring systems. 
  • Predictive capability of left atrial size measured by CT, TEE, and TTE for recurrence of atrial fibrillation following radiofrequency catheter ablation. 
  • Predictors of Cardiac Perforation With Catheter Ablation of Atrial Fibrillation. 
  • Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. 
  • Predictors of recurrence of atrial fibrillation within the first 3 months after ablation. 
  • Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. 
  • Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial Fibrillation. 
  • Procedure characteristics and outcomes of atrial fibrillation ablation procedures using cryoballoon versus radiofrequency ablation: A report from the GWTG-AFIB registry. 
  • Progression of renal tumors after laparoscopic radiofrequency ablation. 
  • Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. 
  • Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. 
  • Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation. 
  • Pulmonary Vein Isolation With a Pace Capture-Guided Approach: Durable or Debatable? 
  • Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation. 
  • Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. 
  • Pulmonary venous infarction after radiofrequency ablation for atrial fibrillation. 
  • Quantitative assessment of the recovery property of atriofascicular/atrioventricular-type Mahaim fiber. 
  • Radiofrequency Ablation Provides Rapid and Durable Pain Relief for the Palliative Treatment of Lytic Bone Metastases Independent of Radiation Therapy: Final Results from the OsteoCool Tumor Ablation Post-Market Study. 
  • Radiofrequency Ablation in the Sinus of Valsalva for Ventricular Arrhythmia in Pediatric Patients. 
  • Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers. 
  • Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. 
  • Radiofrequency ablation for primary lung cancer and pulmonary metastases. 
  • Radiofrequency ablation: the effect of distance and baseline temperature on thermal dose required for coagulation. 
  • Radiofrequency catheter ablation for dyssynchrony-induced dilated cardiomyopathy in an infant. 
  • Radiofrequency catheter ablation of multiple haemodynamically unstable ventricular tachycardias in a patient with surgically repaired tetralogy of Fallot. 
  • Radiofrequency catheter ablation of supraventricular tachycardia substrates after mustard and senning operations for d-transposition of the great arteries. 
  • Radiologic-pathologic analysis of increased ethanol localization and ablative extent achieved by ethyl cellulose. 
  • Randomized Clinical Trials of Catheter Ablation of Atrial Fibrillation in Congestive Heart Failure: Knowns and Unmet Needs. 
  • Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. 
  • Rates and predictors of hospital and emergency department care after catheter ablation of atrial fibrillation. 
  • Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation. 
  • Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective. 
  • Real-time 3-dimensional transesophageal echocardiography during left atrial radiofrequency catheter ablation for atrial fibrillation. 
  • Real-time 3D color flow Doppler for guidance of vibrating interventional devices. 
  • Real-time monitoring of luminal esophageal temperature during left atrial radiofrequency catheter ablation for atrial fibrillation: observations about esophageal heating during ablation at the pulmonary vein ostia and posterior left atrium. 
  • Real-time sonoelastography of hepatic thermal lesions in a swine model. 
  • Real-time three-dimensional intracardiac echocardiography. 
  • Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). 
  • Recent Advances in Lesion Formation for Catheter Ablation of Atrial Fibrillation. 
  • Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. 
  • Recurrent Post-Ablation Paroxysmal Atrial Fibrillation Shares Substrates With Persistent Atrial Fibrillation : An 11-Center Study. 
  • Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. 
  • Renal function outcomes for multifocal renal neoplasms managed by radiofrequency ablation. 
  • Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries. 
  • Reply to the Editor- Contact force-sensing catheters and increased risk of atrioesophageal fistula: Is the tool to blame or the workmen? 
  • Reply: Intracardiac Versus Transesophageal Echocardiography: If You Don't Compare Them You Don't Have the Answer. 
  • Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. 
  • Reversible cardiomyopathies--a review. 
  • Rhythm control in atrial fibrillation. 
  • Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation. 
  • Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital. 
  • Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 
  • Risk assessment in atrial fibrillation: not all factors are created equal. 
  • Risk of atrioesophageal fistula formation with contact force-sensing catheters. 
  • Role of Thyroid RFA in the Treatment of Autonomously Functioning Thyroid Nodules. 
  • Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. 
  • Rupture of benign thyroid tumors after radio-frequency ablation. 
  • Sacroiliac joint radiofrequency ablation with a multilesion probe: a case series of 60 patients. 
  • Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. 
  • Safety of slow pathway ablation in patients with long PR interval: further evidence of fast and slow pathway interaction. 
  • Selective vs. Global Renal Denervation: a Case for Less Is More. 
  • Sex Differences in Ablation Strategy, Lesion Sets, and Complications of Catheter Ablation for Atrial Fibrillation: An Analysis From the GWTG-AFIB Registry. 
  • Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5. 
  • Should His Bundle Pacing Be Preferred over Cardiac Resynchronization Therapy Following Atrioventricular Junction Ablation? 
  • Strategies to minimize the risk of esophageal injury during catheter ablation for atrial fibrillation. 
  • Surgical ablation of atrial fibrillation trends and outcomes in North America. 
  • Surgical atrial fibrillation ablation: a review of contemporary techniques and energy sources. 
  • Symptom challenges after atrial fibrillation ablation. 
  • T1 Mapping in Patients With Nonischemic Cardiomyopathy Undergoing Catheter Ablation: Moving Beyond Late Gadolinium Enhancement. 
  • Technique for CT Fluoroscopy-Guided Lumbar Medial Branch Blocks and Radiofrequency Ablation. 
  • Temperature-controlled and constant-power radio-frequency ablation: what affects lesion growth? 
  • The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. 
  • The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The association of left atrial low-voltage regions on electroanatomic mapping with low attenuation regions on cardiac computed tomography perfusion imaging in patients with atrial fibrillation. 
  • The best that surgery has to offer. 
  • The comparison of epicardial focused ultrasound circumferential pulmonary vein ablation and BOX ablation--results from experimental acute atrial fibrillation. 
  • The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. 
  • The feasibility of myocardial infarct visualization using atrial kick induced strain (AKIS) contrast. 
  • The impact of new and emerging clinical data on treatment strategies for atrial fibrillation. 
  • The interplay between autonomic tone and atrial arrhythmias. 
  • The oligometastatic state - separating truth from wishful thinking. 
  • The rise of ablative technologies for treating the small renal mass. 
  • The role of atrial fibrillation catheter ablation in patients with heart failure. 
  • The role of posterior wall isolation in catheter ablation of persistent atrial fibrillation. 
  • Thoracoscopic resection of the left atrial appendage after failed focal atrial tachycardia ablation. 
  • Three year's experience with the Stretta procedure: did it really make a difference? 
  • To ablate or not to ablate?: that is the question. 
  • Transthoracic percutaneous access for electroanatomic mapping and catheter ablation of atrial tachycardia in patients with a lateral tunnel Fontan. 
  • Treatment of older patients with atrial fibrillation by morbidity burden. 
  • Treatment of primary varicose veins has changed with the introduction of new techniques. 
  • Treatment of supraventricular tachycardias with transcatheter delivery of radiofrequency current. 
  • Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging Substudy. 
  • Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver. 
  • Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions? 
  • Update on radiofrequency ablation. 
  • Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma. 
  • Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. 
  • Use of ventricular synchronized triggered atrial pacing to facilitate hemodynamic support during mapping and catheter ablation of ventricular vachycardia. 
  • Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation. 
  • Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation. 
  • Ventricular tachycardia induced cardiomyopathy: improvement with radiofrequency ablation. 
  • Visualization of the esophagus during catheter ablation of atrial fibrillation. 
  • When ablating over epicardial fat, consider the path of least resistance! 
  • Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Dupre, Matthew E., Associate Professor in Population Health Sciences, Center for the Study of Aging and Human Development
  • Friedman, Daniel, Assistant Professor of Medicine, Medicine, Cardiology
  • Nightingale, Kathryn Radabaugh, Theo Pilkington Distinguished Professor of Biomedical Engineering, Biomedical Engineering